Clinical trials
Phase 1 Obesity trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2016 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Not yet recruiting | 6 |
| Recruiting | 6 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Zafgen, Inc. | 3 |
| Biolexis Therapeutics | 2 |
| NGM Biopharmaceuticals, Inc | 2 |
| Sciwind Biosciences APAC CO Pty. Ltd. | 2 |
| Shanghai Minwei Biotechnology Co., Ltd | 2 |
| Allysta Pharmaceutical | 1 |
| Altimmune, Inc. | 1 |
| Atridia Pty Ltd. | 1 |
| Biomed Industries, Inc. | 1 |
| CSPC Megalith Biopharmaceutical Co.,Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 30 |
| Overweight | 18 |
| Diabetes Mellitus, Type 2 | 5 |
| Non-alcoholic Fatty Liver Disease | 3 |
| Metabolic Diseases | 2 |
| Idiopathic Pulmonary Fibrosis | 1 |
| Weight Loss | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.